EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Molecular pathway of pancreatic cancer‐associated neuropathic pain

Shweta Subhash Giri, Alok Shiomurti Tripathi, Pınar Erkekoğlu, Magdi E A Zaki

Journal of Biochemical and Molecular Toxicology · 2024-04 · 38 (4)

DOI: 10.1002/jbt.23638 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 13.04.2024. Verfasst von Shweta Subhash Giri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Neuralgia, Pancreatic Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 192 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pancreas is a heterocrine gland that has both exocrine and endocrine parts. Most pancreatic cancer begins in the cells that line the ducts of the pancreas and is called pancreatic ductal adenocarcinoma (PDAC). PDAC is the most encountered pancreatic cancer type. One of the most important characteristic features of PDAC is neuropathy which is primarily due to perineural invasion (PNI). PNI develops tumor microenvironment which includes overexpression of fibroblasts cells, macrophages, as well as angiogenesis which can be responsible for neuropathy pain. In tumor microenvironment inactive fibroblasts are converted into an active form that is cancer‐associated fibroblasts (CAFs). Neurotrophins they also increase the level of Substance P, calcitonin gene‐related peptide which is also involved in pain. Matrix metalloproteases are the zinc‐associated proteases enzymes which activates proinflammatory interleukin‐1β into its activated form and are responsible for release and activation of Substance P which is responsible for neuropathic pain by transmitting pain signal via dorsal root ganglion. All the molecules and their role in being responsible for neuropathic pain are described below.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaPancreatic NeoplasmsHumansSubstance PPancreasFibroblastsTumor Microenvironment

Stichwörter der Autor:innen

PDAC neuropathybrain‐derived neurotrophic factors (BDNF)mucin 1 (MUC1)myelin‐associated glycoprotein (MAG)nerve growth factor (NGF)perineural invasionslit guidance ligand 2 (SLIT2)tumor microenvironment

Substanzen

Substance P

Autor:innen und Institutionen

  • Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India.
  • Department of Pharmacology, Era College of Pharmacy, Era University, Lucknow, Uttar Pradesh, India.
  • Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
  • Department of Chemistry, Faculty of Science, Imam Mohammad lbn Saud Islamic University, Riyadh, Saudi Arabia.

Zitieren

APA

Giri, S. S., Tripathi, A. S., Erkekoğlu, P., & Zaki, M. E. A. (2024). Molecular pathway of pancreatic cancer‐associated neuropathic pain. Journal of Biochemical and Molecular Toxicology, 38(4). https://doi.org/10.1002/jbt.23638

Vancouver

Giri SS, Tripathi AS, Erkekoğlu P, Zaki MEA. Molecular pathway of pancreatic cancer‐associated neuropathic pain. Journal of Biochemical and Molecular Toxicology. 2024;38(4). doi:10.1002/jbt.23638

BibTeX
@article{Giri2024,
  author = {Giri, Shweta Subhash and Tripathi, Alok Shiomurti and Erkekoğlu, Pınar and Zaki, Magdi E A},
  title = {Molecular pathway of pancreatic cancer‐associated neuropathic pain},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2024},
  volume = {38},
  number = {4},
  doi = {10.1002/jbt.23638}
}
Kostenlos starten →